This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignees: Helsinn Healthcare Sa, Roche Palo Alto LLC, Helsinn Advanced Synthesis Sa. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Biasca, CH (2006)
- Pazzallo, CH (2011)
Company Filing History:
3 out of 70 
3 out of 322 
1 out of 1 Years Active: 2006-2011
Title: Enrico Braglia: Innovator in Pharmaceutical Formulations
Introduction
Enrico Braglia is a notable inventor based in Pazzallo, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liquid formulations for medical use. With a total of 4 patents, his work has had a meaningful impact on the treatment of patients undergoing chemotherapy and radiotherapy.
Latest Patents
One of his latest patents focuses on liquid pharmaceutical formulations of palonosetron. This invention relates to shelf-stable liquid formulations designed to reduce chemotherapy and radiotherapy-induced emesis. The formulations are particularly useful in the preparation of both intravenous and oral liquid medicaments. This innovation is crucial for improving patient comfort and treatment efficacy.
Career Highlights
Throughout his career, Enrico Braglia has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Helsinn Healthcare SA and Roche Palo Alto LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Enrico has collaborated with several professionals in his field, including Riccardo Braglia and Giorgio Calderari. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Enrico Braglia stands out as an influential inventor in the pharmaceutical sector, with a focus on improving patient care through innovative formulations. His contributions continue to shape the landscape of medical treatments, making a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile